The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study
Alzheimer's & Dementia · 2026-01 · 22 (1)
DOI: 10.1002/alz.70981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.01.2026. Verfasst von Kyu Yeong Choi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Gwangju Alzheimer's and Related Dementia Cohort Research Center, Chosun University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the KBRI Basic Research Program through the Korea Brain Research Institute, funded by the Ministry of Science and ICT, the Original Technology Research Program for Brain Science of the National Research Foundation funded by the Korean government, MSIT, Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation of Korea.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) is a major public health concern in Korea, with a high prevalence among older adults. A community‐based longitudinal study is essential for tracking disease progression, identifying biomarkers, and developing targeted prevention and treatment strategies. The Gwangju Alzheimer's & Related Dementias (GARD) cohort was established to address these needs through a multimodal approach. METHODS Participants aged ≥60 years undergo comprehensive clinical evaluations, neuroimaging, and biospecimen collection for multi‐omics analyses (genomics, transcriptomics, proteomics, and metagenomics) at baseline and systematic follow‐up visits. RESULTS From over 17,000 screened individuals, 12,877 were enrolled. Baseline diagnoses include 5,123 cognitively unimpaired (CU), 3,250 mild cognitive impairment (MCI), and 2,125 AD dementia. The resource includes magnetic resonance imaging scans ( n = 10,843) and extensive multi‐omics data: genomic ( n = 10,775), proteomic ( n = 116), and microbiome ( n = 595). DISCUSSION The integrated GARD dataset provides a powerful and scalable resource for identifying novel biomarkers, understanding disease heterogeneity, and advancing precision medicine for AD. Highlights Gwangju Alzheimer's & Related Dementias (GARD) is a large‐scale, longitudinal, community‐based cohort study in South Korea. The study focuses on early detection and monitoring of dementia progression. GARD includes cognitive testing, imaging, biospecimens, and multi‐omics data. We aim to identify Korean‐specific biomarkers predictive of cognitive decline. Supports East Asian insights and fills gaps in global Alzheimer's research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gwangju Alzheimer's and Related Dementia Cohort Research Center, Chosun University, Gwangju, Republic of Korea.
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
- Biomedical Genetics Section, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
- Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.
- Department of Biomedical Science and BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju, Republic of Korea.
- Department of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
Förderung
- the KBRI Basic Research Program through the Korea Brain Research Institute, funded by the Ministry of Science and ICT
- the Original Technology Research Program for Brain Science of the National Research Foundation funded by the Korean government, MSIT
- Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation of Korea
- Korea National Institute of Health research project
- by the Technology Innovation Program (20022810, Development and Demonstration of a Digital System for the evaluation of geriatric Cognitive impairment) funded…
- the Technology Innovation Program funded by the Ministry of Trade, Industry & Energy, Republic of Korea
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…
Zitieren
APA
Choi, K. Y., Kang, S., Cook, S., Li, D., Choi, Y. Y., Seo, E. H., Han, X., Park, J. E., Lee, S., Lee, S., Chung, J. Y., Chong, A., Choi, S. M., Ha, J. M., Song, M. K., Lee, J. S., Choo, I. H., Kim, J. H., Song, H. C., …, & Lee, K. H. (2026). The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study. Alzheimer's & Dementia, 22(1). https://doi.org/10.1002/alz.70981
Vancouver
Choi KY, Kang S, Cook S, Li D, Choi YY, Seo EH, et al. The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study. Alzheimer's & Dementia. 2026;22(1). doi:10.1002/alz.70981
BibTeX
@article{Choi2026,
author = {Choi, Kyu Yeong and Kang, Sarang and Cook, Seungho and Li, Donghe and Choi, Yu Yong and Seo, Eun Hyun and Han, Xudong and Park, Jung Eun and Lee, Suyeon and Lee, Sunjae and Chung, Ji Yeon and Chong, Ari and Choi, Seong-Min and Ha, Jung-Min and Song, Min Kyung and Lee, Jung Sup and Choo, Il Han and Kim, Ja-Hae and Song, Ho-Chun and Kim, Byeong C and Kim, Hoowon and Farrer, Lindsay A and Gim, Jungsoo and Jun, Gyungah R and Lee, Kun Ho},
title = {The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {1},
doi = {10.1002/alz.70981}
}
EUVIMED